As healthcare moves toward genetically tailored treatments, one of the biggest hurdles to truly personalized medicine is the lack of fast, low-cost genetic testing. And few people are more familiar with the problems of today’s genetic diagnostics tools than Kalim Mir, the 52-year-old founder of XGenomes, who has spent his entire professional career studying the […]
View More XGenomes is bringing DNA sequencing to the massesCategory: Life Sciences
Mammoth Biosciences adds the final piece of the CRISPR diagnostics puzzle to its toolkit
With the announcement today that Mammoth Biosciences has received the exclusive license from the University of California, Berkeley to the new CRISPR protein Cas14, the company now has the last piece of its diagnostics toolkit in place. Cas14 is a newly discovered protein from the lab of Jennifer Doudna, a pioneer in gene-editing research and […]
View More Mammoth Biosciences adds the final piece of the CRISPR diagnostics puzzle to its toolkitTwo former members of Google’s skunkworks division have launched a biomanufacturing company
Biomanufacturing technologies — taking modified versions of existing organisms and bending them to the will of humans — has moved from the world of science fiction to becoming a new reality. Across the startup landscape companies are launching to make synthetic spider silk, or make leather substitutes, or meat substitutes, or novel chemicals and pharmaceuticals. […]
View More Two former members of Google’s skunkworks division have launched a biomanufacturing companyChina is funding the future of American biotech
Silicon Valley is in the midst of a health craze, and it is being driven by “Eastern” medicine. It’s been a record year for US medical investing, but investors in Beijing and Shanghai are now increasingly leading the largest deals for US life science and biotech companies. In fact, Chinese venture firms have invested more this […]
View More China is funding the future of American biotech